$1,000 invested AbbVie Inc. (2023)
NYSE · ABBV · reinvest dividends · adjusted close
●Result2023-01-03 — 2026-10-15
Today you would have
$1,980
+$980 (+97.99%)
ABBVSPY (benchmark)
- Entry price
- $143.14
- Current price
- $283.40
- Shares
- 6.9864
- CAGR
- +19.80%
- Max Drawdown
- -20.74%
- vs SPY
- -13.41 pp
✦The story
A $1,000 investment in AbbVie at the beginning of 2023 reached $1,980 by July 2026, up +98.0%. This was the period when AbbVie navigated the loss of U.S. exclusivity on Humira, offsetting it with newer immunology drugs Skyrizi and Rinvoq. The S&P 500 gained +111.4% over the same stretch.
#Related scenariosfor comparison
Other years for ABBV